At the University of Minnesota's heart lab, millions of dollars of tubing and wires and technology work to keep a living ...

Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...

Medical device industry veteran brings over three decades of expertise in M&A, as well as structured research and development (“R&D”) ...

Matthew Walter, SVP at Medtronic (NYSE:MDT), reported a large exercise of company stock options on January 28, according to a new SEC filing. What Happened: The latest Form 4 filing on Tuesday ...

CMS' action follows Medtronic's work with the agency to pilot the framework for the Transitional Coverage for Emerging Technologies (TCET) pathway to establish coverage for the Symplicity Spyral ...